The objective of this study was to investigate the effects of L-glutamate (Glu) deficiency or L-trans pyrrolidine-2,4-dicarboxylic acid (PDC) supplementation on the proliferation of pig intestinal epithelial cells (IPEC-1). First, IPEC-1 cells were cultured in normal growing medium supplemented with 0 (Control), 50, 100, or 200 mmol/L PDC to determine an appropriate concentration of PDC supplementation. Second, IPEC-1 cells were cultured in Glu-deficient medium supplemented with 0 mmol/L Glu (Glu deficiency), 50 mmol/L Glu (Control), or 50 mmol/L Glu plus 100 mmol/L PDC (PDC supplementation). Cell proliferation (n = 24), cell cycle distribution (n = 6), cell apoptosis (n = 6), and expression levels of proteins of interest (n = 4) were determined by MTT assay, flow cytometry, or western blot. The results showed that cell proliferation was inhibited (P < 0.05) by 50, 100, and 200 mmol/L PDC supplementation
INTRODUCTION
L-Glutamate (Glu) is the major oxidative fuel for the intestine, and approximately 96% of enteral Glu is converted into a-ketoglutarate to generate ATP, whereas only a minimal amount appears in the portal blood (Reeds et al., 2000) . Previous studies on pigs have demonstrated that excitatory AA transporter 3 (EAAT3) is the most abundant Glu transporter expressed in the jejunal epithelial membrane (Zhang et al., 2013) , and EAAT3 is also a marker gene of intestinal development in chick embryos (Zeng et al., 2011; Li et al., 2013) . at 24 and 48 h after treatment. Variance analysis was performed using the GLM procedure, and the results demonstrated that Glu deficiency or PDC supplementation led to the inhibition (P < 0.05) of cell proliferation, a greater (P < 0.05) percentage of cells in the G1 phase, and a lower (P < 0.05) percentage of cells in the S phase. Moreover, Glu deficiency or PDC supplementation reduced (P < 0.05) the expression levels of excitatory AA transporter 3 (EAAT3), phosphormammalian target of rapamycin (p-mTOR; Ser2448), p-ribosomal protein S6 kinase 1 (S6K1; Thr389), and p-S6 (Ser235/236). This study demonstrates that Glu deficiency or PDC supplementation inhibits proliferation of IPEC-1 cells via downregulation of the mTOR/ S6K1 pathway and EAAT3 expression indicating that Glu deficiency may lead to the disturbances of intestinal epithelial renewal in pigs, particularly in neonates.
L-Glutamate deficiency can trigger proliferation inhibition via down
L-trans pyrrolidine-2,4-dicarboxylic acid (PDC) is a potent competitive inhibitor of EAATs that can significantly decrease Glu uptake (Waagepetersen et al., 2001 ). The neonatal intestinal epithelium has a high rate of cell renewal (Li et al., 2014b) , which suggests that intestinal epithelial cells require a high ATP supply, and Glu supplementation in the pig's diet has a therapeutic function for the improvement of neonatal intestine injury. These results suggest that Glu may be an available nutrient for the maintenance of mucosal health (Burrin and Stoll, 2009) . However, an understanding of the effects of Glu on the characteristics of cells, particularly intestinal epithelial cells, is still lacking. The purpose of the present study was to investigate the effects of Glu deficiency or transport inhibited by PDC on the proliferation, cell cycle progress, apoptosis, and autophagy of pig intestinal epithelial cells and to analyze the 2 signal transduction pathways responsible for sensing AA availability, including the general AA control non-derepressible-2 (GCN2), which senses the absence of AA via direct binding to uncharged cognate tRNA, and the growthregulating kinase mammalian target of rapamycin complex1 (mTORC1; Gallinetti et al., 2013) .
MATERIALS AND METHODS

Reagents
PDC was purchased from TOCRIS Bioscience (Bristol, UK), and Glu was purchased from Sigma-Aldrich (St. Louis, MO). Glu-free DMEM/F12 was prepared by Gibco (Carlsbad, CA), and fetal bovine serum (FBS), epidermal growth factor (eGF), and penicillin-streptomycin were also obtained from Gibco (Carlsbad, CA). Insulin-Transferrin-Selenium (ITS) was purchased from ScienCell (Carlsbad, CA). Cell culture flasks (#430641) and plates (#3599, #3516) were obtained from Corning (Corning, NY). The antibodies used in this study are as follows: anti-mTOR (#2972), anti-phospho (p)-mTOR (Ser2448; #5536), anti-ribosomal protein S6 kinase 1 (S6K1; #9202), anti-p-S6K1 (Thr389; #9205), anti-S6 (#2217), antip-S6 (Ser235/236, #4858), anti-eukaryotic translation initiation factor 4E-binding protein 1 (4EBP1; #9644), anti-p-4EBP1 (Thr70; #2855), and anti-microtubuleassociated protein 1 light chain 3 (LC3; #4108) antibodies from Cell Signaling Technology (Beverly, MA), anti-EAAT3 (sc-25658), anti-transcription factor 4 (ATF4; sc-200), anti-eukaryotic translation initiation factor 2a (eIF2a; sc-133227), and anti-peIF2a (Ser52; sc-101670) antibodies from Santa Cruz (Dallas, TX), and anti-b-actin (AP0060), antirabbit IgG (BS13278), and antimouse IgG (BS30503) antibodies from Bioworld Technology (Louis Park, MN). Unless otherwise indicated, all other chemicals were purchased from Sigma-Aldrich (St. Louis, MO).
Cell Culture and Treatments
IPEC-1 cells were kindly donated by Prof. Guoyao Wu (Texas A&M University), and these cells (passages 52-58) were cultured in cell culture flasks embedded with growing medium (DMEM/F12 containing 5% FBS, 5 µg/mL insulin, 5 µg/mL transferrin, 5 ng/mL selenium, 5 µg/L EGF, 50 µg/mL penicillin, and 4 µg/mL streptomycin). The cells were cultured at 37°C in a humidified atmosphere of 5% CO 2 and 95% air. The medium was changed every 48 h. Before reaching confluence, the IPEC-1 cells were trypsinized with 0.25% trypsin-EDTA (Gibco, Carlsbad, CA) and seeded at a density of 1.5 × 10 4 cells/mL onto 96-well cell culture plates (200 mL/well) or at a density of 5 × 10 4 cells/mL onto 6-well cell culture plates (2 mL/well). After a 24-h period to allow adhesion, the culture medium was discarded, and the corresponding treatment medium was added and changed every 48 h.
To determine an appropriate concentration of PDC supplementation, PCD was added to the growing medium at a final concentration of 0 (Control), 50, 100, or 200 mmol/L for 0, 24, or 48 h, and the cell proliferation was then assessed through the MTT assay. To determine the effects of Glu deficiency or PDC supplementation on proliferation, cell cycle distribution, apoptosis, and the expression levels of proteins of interest, IPEC-1 cells were treated with Glu-deficient medium (Glu-free DMEM/F12 containing 5% FBS, 5 µg/mL insulin, 5 µg/mL transferrin, 5 ng/mL selenium, 5 µg/L EGF, 50 µg/mL penicillin, and 4 µg/mL streptomycin) supplemented with 0 mmol/L Glu (Glu deficiency), 50 mmol/L Glu (Control), or 50 mmol/L Glu plus 100 mmol/L PDC (PDC supplementation) for 0, 24, 48, or 72 h.
MTT Assay
IPEC-1 cells were seeded into 96-well cell culture plates, and their proliferation was assessed as previously described (Li et al., 2014a) . Briefly, 20 mL of 5 mg/mL 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (Mtt) solution (Sigma, St. Louis, MO) was added to each well, and the plate was incubated for 4 h and then centrifuged at 1,400 × g and 25°C for 15 min. After the supernatant was carefully discarded, 150 mL of dimethyl sulfoxide (DMSO) was added to each well, and the plate was slightly shaken for 10 min. The OD value of the product was evaluated using a microplate reader at a wavelength of 490 nm. The results were confirmed by 3 independent experi-ments with 24 wells per treatment. A representative result from the 3 independent experiments is shown.
Flow Cytometry
To determine the effects of Glu deficiency or PDC supplementation on cell cycle distribution or apoptosis, IPEC-1 cells cultured in 6-well plates were collected 24, 48, or 72 h after treatment. Flow cytometry was performed as previously described (Gao et al., 2015a) . Briefly, the cells were washed twice with ice-cold PBS and fixed with 70% ice-cold ethanol overnight at -20°C for cell cycle analysis or fixed with binding buffer (KeyGEN, Nanjing, Jiangsu) for cell apoptosis analysis following the manufacturer's instructions. For cell cycle analysis, the cells were centrifuged at 200 × g and 4°C for 5 min, subsequently resuspended in 1 mL of PBS, treated with 100 mL of 200 mg/mL DNase-free RNase, incubated at 37°C for 30 min, and treated with 100 mL of 1 mg/mL propidium iodide (PI) at room temperature (25°C) for 10 min. Then, 10 4 cells per sample were subjected to flow cytometry using a Becton Dickinson FACScan (BD Biosciences, Franklin Lake, NJ) at 20 pounds per square inch (psi). For cell apoptosis analysis, the cells were mixed with 5 mL of annexin V-FITC before the flow cytometry analysis, and 5 mL of PI was added to the reaction system. The plate was then incubated at room temperature (25°C) for 10 min in the dark. A total of 10 4 cells per sample were ultimately run on a Becton Dickinson FACScan (BD Biosciences) at 20 psi. The results were confirmed by 3 independent experiments with 6 samples per treatment. A representative result from the 3 independent experiments is shown.
Western Blot
To determine the effects of Glu deficiency or PDC supplementation on the expression levels of proteins of interest, IPEC-1 cells cultured in 6-well plates were treated with Glu-deficient medium supplemented with 0, 50 mmol/L Glu (Control), or 50 mmol/L Glu plus 100 mmol/L PDC and collected 48 after treatment. The expression levels of the proteins were determined by western blot as previously described Gao et al., 2015b) . The IPEC-1 cells were washed twice with ice-cold PBS, collected using lysis buffer (RIPA; BioTeke, Beijing, China) that contained 1% Triton-X, 20 mmol/L Tris-HCl (pH = 7.4), 5 mmol/L EDTA, 1 mmol/L phenylmethanesulfonyl fluoride (PMSF), and phosphatase inhibitors, and centrifuged at 14,000 × g and 4°C for 5 min. The protein concentrations of the supernatants were determined using a BCA Protein Assay Reagent Kit (Thermo Fisher Scientific, Rockford, IL). The protein samples were boiled for 10 min, and 15-µg samples were subjected to 5% and 10% SDS gel electrophoresis. The proteins were separated by electrophoresis at 80 V for 20 min and 110 V for 70 min using Tris-glycine running buffer (0.025 mol/L Tris, 0.192 mol/L glycine, and 0.1% SDS, pH 8.3) and then transferred onto a polyvinylidene difluoride (PVDF) membrane using transfer buffer (25 mmol/L Tris, 192 mmol/L glycine, and 10% methanol, pH 8.3). The membranes were blocked in 5% BSA in TBST buffer (20 mmol/L Tris, 500 mmol/L NaCl, and 0.05% Tween-20, pH 7.6) for 3 h at room temperature and then incubated overnight with the primary antibodies [bactin (1:1,000), mTOR (1:1,000), p-mTOR (1:1,000), S6K1 (1:1,000), p-S6K1 (1:1,000), S6 (1:1,000), p-S6 (1:1,000), 4EBP1 (1:1,000), p-4EBP1 (1:1,000), LC3 (1:800), EAAT3 (1:200), ATF4 (1:500), eIF2a (1:500), and p-eIF2a (1:500)] at 4°C. All antibody dilutions were prepared in a TBST buffer. The next day, the membranes were washed 6 times for 5 min each with a TBST buffer and probed with either secondary peroxidase-conjugated antirabbit IgG (1:5,000) or antimouse IgG (1:5,000) for 1 h at room temperature. Immunoreactivity was detected using the ECL Plus chemiluminescence detection kit (Beyotime Institute of Biotechnology, Beyotime, Shanghai, China) in a FluorChem M system (Cell Bioscicences, San Leandro, CA). The band density was obtained using the Image J software after excluding the background density. The expression levels of LC3-I, LC3-II, EAAT3, and ATF4 were normalized to the b-actin expression level. The expression levels of p-eIF2a, p-mTOR, p-S6K1, p-S6, and p-4EBP1 were normalized to the levels of eIF2a, mTOR, S6K1, S6, and 4EBP1, respectively. The results were confirmed by 3 independent experiments with 4 samples per treatment. A representative result from the 3 independent experiments is shown.
Statistical Analysis
The data were processed using the statistical software package SAS 9.1.3 (SAS Inst. Inc., Cary, NC). Differences among groups were determined using the GLM procedure. The data are expressed as the means ± SD. Differences between groups were considered statistically significant if P < 0.05.
RESULTS
Inhibitory Effects of PDC Supplementation on Proliferation of IPEC-1 Cells
The results are shown in Fig. 1 . Compared with the Control group, PDC supplementation inhibited (P < 0.05) cell proliferation at 24 and 48 h after treatment; however, there was no difference (P > 0.05) among the 50, 100, or 200 mmol/L PDC groups at 0, 24, or 48 h after treatment. Based on these results, a PDC supplementation concentration of 100 mmol/L was selected for the following studies.
Effects of Glu Deficiency or PDC Supplementation on Proliferation of IPEC-1 Cells
The effects of Glu deficiency or PDC supplementation on the proliferation of IPEC-1 cells are shown in Fig. 2 . The results indicated that there was no difference (P > 0.05) in cell proliferation among the groups at 24 h after treatment; however, compared with the Control group, Glu deficiency (Glu-D) and PDC supplementation (PDC) decreased (P < 0.05) cell proliferation at 48 and 72 h after treatment.
Effects of Glu Deficiency or PDC Supplementation on the Cell Cycle Distribution of IPEC-1 Cells
To further investigate these differences in proliferation obtained under conditions of Glu deficiency or PDC supplementation, cell cycle analysis was conducted via flow cytometry at 24, 48, or 72 h after treatment. Compared with the Control group, the groups subjected to Glu deficiency (Glu-D) or PDC supplementation (PDC) presented a decrease (P < 0.05) in the percentage of cells in the S phase and an increase (P < 0.05) in the percentage of cells in the G1 phase at 48 h (Fig. 3C ) and 72 h (Fig. 3D ) after treatment.
Effects of Glu Deficiency or PDC Supplementation on Cell Apoptosis and Autophagy of IPEC-1 Cells
Whether Glu deficiency or PDC supplementation results in apoptosis or autophagy was subsequently examined. The results presented in Fig. 4 show that there was no difference (P > 0.05) among the groups in the percentage of apoptotic cells at 48 and 72 h after treatment. In addition, the protein expression level of LC3, which is a marker protein of autophagy (Klionsky et al., 2014) , was determined by western blot at 48 h after treatment. The results showed that the expression levels of LC3-I and LC3-II were not different (P > 0.05) among the groups (Fig. 5) .
Effects of Glu Deficiency or PDC Supplementation on Expression Level of the EAAT3 Protein in IPEC-1 Cells
The effects of Glu deficiency or PDC supplementation on the expression level of the EAAT3 protein are shown in Fig. 6 . Compared with the Control group, the groups subjected to Glu deficiency (Glu-D) and PDC supplementation (PDC) presented decreased (P < 0.05) expression level of the EAAT3 protein. IPEC-1 cells were cultured in Glu-deficient medium (Glufree DMEM/F12 containing 5% FBS, 5 µg/mL insulin, 5 µg/mL transferrin, 5 ng/mL selenium, 5 µg/L EGF, 50 µg/mL penicillin, and 4 µg/mL streptomycin) supplemented with 0 mmol/L Glu (Glu-D), 50 mmol/L Glu (Control), or 50 mmol/L Glu plus 100 mmol/L PDC (PDC). Cell proliferation was measured through the MTT assay at 0, 24, 48, or 72 h after treatment. The results were confirmed by 3 independent experiments with 24 wells per treatment. The results shown are representative of 3 independent experiments. The bars represent the means ± SD, n = 24. Different letters indicate significant differences (P < 0.05).
Effects of Glu Deficiency or PDC Supplementation on the Expression Levels of mTOR and GCN2 Pathway-Related Proteins in IPEC-1 Cells
The following experiment was attempted to verify whether mTOR or GCN2 is responsible for the effects of Glu deficiency or PDC supplementation in IPEC-1 cells obtained at 48 h after treatment. The results indicated that Glu deficiency or PDC supplementation did not change (P > 0.05) the protein expression levels of ATF4 (Fig. 7A ) and p-eIF2a (Ser52 ; Fig. 7B) ; however, compared with the Control group, Glu deficiency (Glu-D) or PDC supplementation (PDC) decreased (P < 0.05) the expression levels of p-mTOR (Ser2448; Fig. 8A ), p-S6K1 (Thr389; Fig. 8B ), and p-S6 (Ser235/236; Fig. 8C ). There was no change (P > 0.05) in the protein level of p-4EBP1 (Thr70; Fig. 8C ).
DISCUSSION
The gastrointestinal tract is the body's largest immune organ and the place of nutrient digestion and absorption, and gastrointestinal activity plays important roles in nutrition and health (Yao et al., 2012) . Many stressful conditions, such as early weaning, infection, and inflammation, are associated with intestinal mucosal injury, and gastrointestinal dysfunction endangers the health, development, and survival of the body (Li et al., 2014b) . Extensive studies have demonstrated that intestinal development is regulated by dietary and maternal nutrition, hormones, and critical genes. The AA, which are the building blocks of proteins, play a key role in controlling intestinal injury and homeostasis (Bertrand et al., 2013) . Glutamine and glutamate are members of AA of glutamate family which are disposed of through conversion to glutamate (Tapiero et al., 2002) . Previous study showed that extracellular conversion of glutamine to glutamate activated by gglutamyltransferase and subsequent uptake of glutamate mediated by specific glutamate transporters is a crucial step in the protective effect of glutamine on intestinal integrity (Vermeulen et al., 2011) . Although Glu is traditionally considered a non-essential AA, it is the major fuel for the intestinal mucosa. Studies regarding the effects of Glu on proteins or key molecule synthesis, nutrient uptake, anti-oxidative, and signaling have been conducted over the previous decades (Brosnan and Brosnan, 2013) . Rezaei et al. (2013) reported that dietary supplementation with monosodium Glu could improve growth performance in piglets, and previous studies showed that PDC administration decreases the growth of the small intestine in chick embryos (Li et al., 2014b) . The AA starvation response has been studied for many years, and the results have mainly been obtained from essential AA starvation because non-essential AA can be synthesized by cells (Meng et al., 2014) . The present study assessed whether Glu plays a role in the regulation of cell proliferation. Although there was no difference in cell proliferation among the groups at 24 h after treatment with Glu-deficient medium or PDC supplementation, a markedly lower cell proliferation was observed at 48 and 72 h after treatment in this study. To the best of our knowledge, this report provides the first demonstration of the regulation of pig intestinal cell proliferation by Glu deficiency or PDC supplementation. These results suggest further research on glutamate in feeding. . Effects of L-glutamate (Glu) deficiency or L-trans pyrrolidine-2,4-dicarboxylic acid (PDC) supplementation on expression level of excitatory AA transporter 3 (EAAT3) in IPEC-1 cells. IPEC-1 cells were cultured in Glu-deficient medium (Glu-free DMEM/F12 containing 5% FBS, 5 µg/mL insulin, 5 µg/mL transferrin, 5 ng/mL selenium, 5 µg/L EGF, 50 µg/mL penicillin, and 4 µg/mL streptomycin) supplemented with 0 mmol/L Glu (Glu-D), 50 mmol/L Glu (Control), or 50 mmol/L Glu plus 100 mmol/L PDC (PDC). After a 48-h treatment period, the cells were collected to determine the expression level of EAAT3 protein through western blot with specific antibodies. The results were confirmed by 3 independent experiments with 4 samples per treatment. The results shown are representative of 3 independent experiments. The bars represent the means ± SD, n = 4. Different letters indicate significant differences (P < 0.05). Figure 8 . Effects of L-glutamate (Glu) deficiency or L-trans pyrrolidine-2,4-dicarboxylic acid (PDC) supplementation on expression levels of mammalian target of rapamycin (mTOR) pathway-related proteins in IPEC-1 cells. IPEC-1 cells were cultured in Glu-deficient medium (Glu-free DMEM/F12 containing 5% FBS, 5 µg/mL insulin, 5 µg/mL transferrin, 5 ng/mL selenium, 5 µg/L EGF, 50 µg/mL penicillin, and 4 µg/mL streptomycin) supplemented with 0 mmol/L Glu (Glu-D), 50 mmol/L Glu (Control), or 50 mmol/L Glu plus 100 mmol/L PDC (PDC). After a 48-h treatment period, the cells were collected to determine the expression levels of mTOR, phospho (p)-mTOR, ribosomal protein S6 kinase 1 (S6K1), p-S6K1, S6, p-S6, eukaryotic translation initiation factor 4E-binding protein 1 (4EBP1), and p-4EBP1 through western blot with specific antibodies. The results were confirmed by 3 independent experiments with 4 samples per treatment. The results shown are representative of 3 independent experiments. The bars represent the means ± SD, n = 4. Different letters indicate significant differences (P < 0.05). Figure 7 . Effects of L-glutamate (Glu) deficiency or L-trans pyrrolidine-2,4-dicarboxylic acid (PDC) supplementation on expression levels of transcription factor 4 (ATF4) and phospho-eukaryotic translation initiation factor 2a (p-eIF2a; Ser52) proteins in IPEC-1 cells. IPEC-1 cells were cultured in Glu-deficient medium (Glu-free DMEM/F12 containing 5% FBS, 5 µg/mL insulin, 5 µg/mL transferrin, 5 ng/mL selenium, 5 µg/L EGF, 50 µg/mL penicillin, and 4 µg/mL streptomycin) supplemented with 0 mmol/L Glu (Glu-D), 50 mmol/L Glu (Control), or 50 mmol/L Glu plus 100 mmol/L PDC (PDC). After a 48-h treatment period, the cells were collected to determine the expression levels of ATF4 and p-eIF2a (Ser52) proteins through western blot with specific antibodies. The results were confirmed by 3 independent experiments with 4 samples per treatment. The results shown are representative of 3 independent experiments. The bars represent the means ± SD, n = 4.
Cell proliferation is a process through which cells reproduce themselves by growing and dividing into 2 equal cells (Berridge, 2014) . Cell cycle progression and cell growth interact with each other to sustain the proliferative response (Neufeld and Edgar, 1998; Polymenis and Schmidt, 1999) . To understand how proliferation is controlled under conditions of Glu deficiency or PDC supplementation, the DNA content of IPEC-1 cells was tested at 24, 48, and 72 h after treatment to determine the distribution of cells in the G1, S, and G2 phases of the cell cycle. The results of the present study demonstrated that after culturing in Glu-deficient medium or medium with PDC supplementation for 48 or 72 h, the percentage of cells in the G1 phase was significantly increased compared with the percentages in the Control group, whereas the percentage of cells in the S phase was significantly decreased. These results imply that Glu deficiency or PDC supplementation decreases the rate of cell progression from the G1 to S phase.
Apoptosis is a model of programed cell death that is present during injuries (Malhi et al., 2006) , and the apoptotic process requires ATP (Eguchi et al., 1997) . The Glu has been considered a fuel for the intestinal epithelial cells; thus, this study tested the effects of Glu on apoptosis of IPEC-1 cells. The results of the present study showed that compared with the Control group, Glu deficiency or PDC supplementation had no effect on IPEC-1 apoptosis. In addition, there has been an explosion of studies regarding the fundamental cell biology activity referred to as autophagy (Mizushima and Levine, 2010) , which is an intracellular selfdegradation process that ensures the metabolic balance and homeostasis of cells (Reggiori, 2006) . This process has been linked to many physiological and pathological processes since it was identified in 1963 (Mizushima and Levine, 2010) . Under pathological conditions, such as nutrient starvation, hypoxia, heat stress, and other stimulates, autophagy activity can be markedly up-regulated (Cadwell et al., 2008) . Onodera and Ohsumi (2005) reported that autophagy is necessary for the maintenance of the AA levels and protein synthesis under starvation conditions. Fulceri et al. (2011) demonstrated that Glu-induced motor neuron loss leads to autophagy activation, and Kim et al. (2009) used a Glu-induced oxidative model in murine hippocampal HT22 cells to identify a similar activation of autophagy during Glu-induced HT22 cell death. This study identified the expression of LC3, which is broadly used as a marker to evaluate autophagy (Klionsky et al., 2014) , and the results showed that Glu deficiency or PDC supplementation had no effect on the expression levels of LC3-I or LC3-II. In contrast to previous studies, this study indicates that the apoptosis and autophagy processes do not participate in inhibition of IPEC-1 growth triggered by Glu deficiency or PDC supplementation.
To identify the mechanism through which Glu deficiency or PDC supplementation results in inhibition of proliferation of IPEC-1 cells, this study focused on the GCN2 and mTORC1 pathways, which are involved in the regulation of protein metabolism in response to AA availability. The mTORC1, a serine/ threonine kinase, is best known for its function in the control of cell size and proliferation, and this kinase is typically activated by energy, AA, and growth factors (Bai and Jiang, 2010; Gao et al., 2015b) . The most studied downstream effectors of mTORC1 are 4EBP1 and S6K1, and the phosphorylation of these proteins is typically used as a marker for mTORC1 activity (Gallinetti et al., 2013) . In addition to AA deficiency, the corresponding uncharged aminoacyl-tRNA accumulate and compete with the A-site of ribosomes for binding charged tRNA. This leads to the activation of GCN2 kinase, which triggers the GCN2-induced phosphorylation of eIF2a at serine 51, resulting in reduced protein translation (Zhang et al., 2002) . The translation of specific mRNA, such as ATF4, is upregulated, and ATF4 then increases the expression of stress-related genes . The GCN2 signaling pathway can be rapidly activated in the brain and liver in the absence of AA, including leucine, histidine, tryptophan, and lysine (Gallinetti et al., 2013) . The results of the present study showed that Glu deficiency or PDC supplementation had no effect on the expression levels of p-eIF2a and ATF4 and that Glu deficiency or PDC supplementation did not activate the GCN2/ATF4 pathway. Hara et al. (1998) reported that AA deficiency leads to a rapid de-phosphorylation of S6K1 and 4EBP1 in Chinese-hamster ovary cells. Zepeda et al. (2009) identified a time-and dose-dependent increase in the phosphorylation level of mTORC1 in chick cerebellar Bergmann glia primary cultures after Glu treatment. The results of the present study showed that Glu deficiency or PDC supplementation decreased the expression levels of EAAT3, p-mTOR, p-S6K1, and p-S6 but had no effect on p-4EBP1. Almilaji et al. (2012) reported that mTOR increases EAAT3 protein expression in Xenopus oocyte cell membranes and then accelerates Glu transport. The results of the current study indicate that Glu deficiency or PDC supplementation inactivates the mTOR/S6K1 pathway and then decreases EAAT3 protein expression.
In summary, this study demonstrates that Glu deficiency or PDC supplementation inhibits proliferation of IPEC-1 cells via downregulation of the mTOR/ S6K1 pathway and EAAT3 expression indicating that Glu deficiency may lead to the disturbances of intestinal epithelial renewal in pigs, particularly in neonates.
